The Interplay Between the Gut Microbiome and Immunotherapy in Gastrointestinal Malignancies: Mechanisms, Clinical Implications, And Therapeutic Potential
Abstract
Background: The gut microbiome has emerged as a critical modulator of host immune responses, significantly influencing the efficacy of immunotherapy in gastrointestinal (GI) cancers, including colorectal carcinoma (CRC), gastric cancer (GC), and esophageal adenocarcinoma (EAC). Emerging evidence suggests that microbial dysbiosis can either potentiate or impede immune checkpoint inhibitors (ICIs), adoptive cell therapies, and cancer vaccines.
Objective: This review synthesizes current knowledge on the bidirectional crosstalk between the gut microbiota and antitumor immunity, focusing on molecular mechanisms, preclinical models, and clinical trials evaluating microbiome-based interventions to enhance immunotherapy outcomes.
Methods: A systematic literature review was conducted using PubMed, EMBASE, and Cochrane databases, prioritizing studies on fecal microbiota transplantation (FMT), probiotics, and microbial biomarkers predictive of immunotherapy response.
Results: Specific commensal bacteria (e.g., Akkermansia muciniphila, Bifidobacterium spp., Faecalibacterium prausnitzii) are associated with improved ICI response via dendritic cell activation, CD8+ T-cell infiltration, and reduced regulatory T-cell (Treg) suppression. Conversely, antibiotic-induced microbiota depletion correlates with diminished pembrolizumab and nivolumab efficacy. Clinical trials testing FMT in refractory melanoma and CRC demonstrate restored therapeutic sensitivity, suggesting translatability to GI…
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.